<DOC>
	<DOCNO>NCT00632008</DOCNO>
	<brief_summary>The purpose study determine whether application soluble beta-glucan ( SBG ) onto diabetic foot ulcer improve heal ulcer .</brief_summary>
	<brief_title>Soluble Beta-glucan ( SBG ) Treatment Diabetic Foot Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>Type 1 Type 2 diabetes mellitus Age â‰¥ 18 year One fullthickness ulcer level malleoli , extend tendon , joint , bone The ulcer ( index ulcer , appropriate ) must present least 4 week prior Day 0 longer 2 year Ankle : brachial pressure index ( ABPI ) &gt; 0.7 , presence two palpable pulse affect foot Ulcer area &gt; 25 mm2 &lt; 500 mm2 Written inform consent Pregnancy , lactation absence adequate contraception woman child bear capacity ABPI &lt; 0.7 Serum albumin &lt; 2.0 g/dL Gangrene part foot study ulcer Presence sign clinically significant foot infection Day 0 Chronic renal failure calculate GFR &lt; 30 ml/min Surgical procedure ( debridement ) foot study ulcer 28 day prior Day 0 HbA1c 12 % Current alcohol drug abuse Participation study precede 28 day An ulcer foot affect acute Charcot osteoarthropathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>